• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Skip to investors navigation
Insmed

Insmed

Powered by Purpose

LinkedIn Twitter Contact Us Job Opportunities

  • Culture
    • Our Culture
      • Mission & Vision
      • Careers
      • Responsibility
        • Inclusion at Insmed
        • Grants & Funding
        • Global Healthcare Compliance

    Our Global Company

    Find available career opportunities in the U.S., Japan, or Europe.

    Find Jobs

  • Patients
    • Our Patients
      • Disease Areas
        • NTM Lung Disease
        • Bronchiectasis
        • Pulmonary Arterial Hypertension
      • Resources
      • Patient Access

    Current Clinical Trials

    You may be eligible for one of our clinical trials.

    See if you may qualify

  • Science
    • Our Science
      • ARIKAYCE®
      • Our Programs
      • Pipeline
      • Clinical Trials
      • Our Research Team
      • Investigator-Initiated Research

    Our Research Team

    Working together to develop new medicines and technologies that have the potential to transform patients’ lives.

    Learn More

  • About
    • About Insmed
    • Management Team
    • Board of Directors
    • Partnerships
  • Investors
    • Investors
    • Events & Presentations
    • Stock Information
    • News Releases
    • SEC Filings
    • Annual Reports
    • Analyst Coverage
    • Corporate Governance
    • Email Alerts
    • Investor FAQs
Home / Investors/ News Releases

News Releases

Month Year
Su Mo Tu We Th Fr Sa
Month Year
Su Mo Tu We Th Fr Sa
Email Alerts
Advanced Search
  
Asset Types
           
 Basic Search
  • Aug 31, 2016
    Insmed Announces Upcoming Presentations at European Respiratory Society 2016 International Congress
  • Aug 4, 2016
    Insmed Reports Second Quarter 2016 Financial Results
  • Jun 8, 2016
    Insmed Announces Withdrawal of Marketing Authorization Application for ARIKAYCE™ in Europe
  • May 9, 2016
    Insmed to Present at the Bank of America Global Healthcare Conference
  • May 5, 2016
    Insmed Reports First Quarter 2016 Financial Results
  • May 3, 2016
    Insmed Announces Upcoming Presentations at the American Thoracic Society 2016 International Meeting
  • Mar 2, 2016
    Insmed to Present at the 36th Annual Cowen & Company Healthcare Conference
  • Feb 25, 2016
    Insmed Reports Fourth Quarter 2015 Financial Results
  • Jan 5, 2016
    Insmed to Present at the 34th Annual J.P. Morgan Healthcare Conference
  • Nov 24, 2015
    Insmed to Present at the Piper Jaffray 27th Annual Healthcare Conference
  • Nov 11, 2015
    Insmed to Present at the Stifel 2015 Healthcare Conference
  • Nov 6, 2015
    Insmed Reports Third Quarter 2015 Financial Results and Provides Business Update
  • Oct 31, 2015
    Insmed to Host Third Quarter 2014 Financial Results Conference Call on Thursday, November 6, 2014
  • Oct 29, 2015
    Insmed to Host Third Quarter 2015 Financial Results Conference Call on Friday, November 6, 2015
  • Oct 26, 2015
    Insmed Announces Upcoming Data Presentation at AMCP Nexus 2015
  • Oct 19, 2015
    The Balancing Act(R) on Lifetime to Feature NTM Lung Disease
  • Oct 14, 2015
    INSMED Launches Comprehensive Educational Campaign to Raise Awareness of NTM Lung Disease
    NTMfacts.com Provides a Dynamic Resource for Healthcare Providers to Learn More About NTM Lung Disease Through Patient Testimonials and Case Studies
  • Oct 6, 2015
    Insmed Announces Upcoming Data Presentations at Infectious Disease Week 2015
  • Sep 22, 2015
    Insmed Announces Upcoming Data Presentations at ERS 2015
  • Sep 14, 2015
    Insmed Announces Upcoming Data Presentations at ICAAC/ICC 2015
  • Sep 5, 2015
    Insmed to Present at the Rodman & Renshaw Annual Global Investment Conference
  • Sep 3, 2015
    Insmed to Present at the Leerink Partners Rare Disease Roundtable
  • Aug 11, 2015
    Insmed Announces Proposed Public Offering of Common Stock
  • Aug 6, 2015
    Insmed Reports Second Quarter 2015 Financial Results and Provides Business Update
  • Jul 28, 2015
    Insmed to Host Second Quarter 2015 Financial Results Conference Call on Thursday, August 6, 2015
  • Jun 17, 2015
    Insmed to Participate at the JMP Securities Life Sciences Conference
  • May 13, 2015
    Insmed Announces Upcoming Data Presentations at the American Thoracic Society 2015 International Meeting
  • May 11, 2015
    Insmed to Participate at the UBS Global Healthcare Conference
  • May 7, 2015
    Insmed Reports First Quarter 2015 Financial Results
  • Apr 6, 2015
    Insmed Announces Closing of Public Offering and Exercise of Option to Purchase Additional Shares
  • Mar 31, 2015
    Insmed Announces Pricing of Public Offering of Common Stock
  • Mar 30, 2015
    Insmed Announces Proposed Public Offering of Common Stock
  • Mar 27, 2015
    Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
  • Mar 23, 2015
    Insmed Appoints Dr. Eugene Sullivan as Chief Medical and Scientific Officer
    20 Year Industry Veteran Brings Industry, Clinical and Regulatory Experience in Pulmonary and Orphan Diseases
  • Feb 27, 2015
    Insmed Reports 2014 Fourth Quarter and Full Year Financial Results
    Marketing Authorization Application for ARIKAYCETM Validated by the European Medicines Agency
  • Feb 24, 2015
    Insmed to Participate at Cowen & Company's 35th Annual Health Care Conference
  • Jan 28, 2015
    Insmed to Participate at February Investment Conferences
  • Jan 13, 2015
    Insmed Incorporated Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
  • Jan 6, 2015
    Insmed to Present at the 33rd Annual J.P. Morgan Healthcare Conference
  • Dec 15, 2014
    Insmed Provides End of Year Regulatory and Clinical Update
  • Dec 15, 2014
    Insmed Appoints Myrtle Potter to its Board of Directors
    Pharmaceutical executive brings 30 years of commercial and operations leadership
  • Nov 26, 2014
    Insmed to Participate at December Investment Conferences
  • Nov 6, 2014
    Insmed Reports Third Quarter 2014 Financial Results
    Conference Call Begins Today at 8:30 a.m. Eastern Time
  • Sep 24, 2014
    Insmed to Participate in Leerink Partners' Rare Disease Roundtable
  • Sep 3, 2014
    Insmed Announces Multiple Clinical and Scientific Presentations at European Respiratory Society's International Congress 2014
  • Aug 18, 2014
    Insmed Announces Closing of Public Offering and Exercise of Option to Purchase Additional Shares
  • Aug 12, 2014
    Insmed Announces Pricing of Public Offering of Common Stock
  • Aug 6, 2014
    Insmed Reports Second Quarter 2014 Financial Results
  • Aug 4, 2014
    Insmed Provides Regulatory Update for ARIKAYCE
    Filing Marketing Authorization Application with European Medicines Agency for NTM Lung Disease and CF Indications
  • Jun 20, 2014
    Insmed to Present at the JMP Securities Healthcare Conference
Show 5102550100 per page
  • «
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 13
  • »
Stay In The Loop

Want to stay up to date on our news, events, and filings? Set up your
email alerts.

Sign Up

View the latest Insmed Investor Presentation

Download

Primary Sidebar

Investor Menu

  • Investors
  • Events & Presentations
  • Stock Information
  • News Releases
  • SEC Filings
  • Annual Reports
  • Analyst Coverage
  • Corporate Governance
  • Email Alerts
  • Investor FAQs

Investor Menu

Footer

Insmed
LinkedIn Twitter

Contact Us

Job Opportunities

  • Our Culture
    • Mission & Vision
    • Careers
    • Responsibility
      • Inclusion at Insmed
      • Grants & Funding
      • Global Healthcare Compliance
  • Our Patients
    • Disease Areas
      • NTM Lung Disease
      • Bronchiectasis
      • Pulmonary Arterial Hypertension
    • Resources
    • Patient Access
  • Our Science
    • ARIKAYCE®
    • Our Programs
    • Pipeline
    • Clinical Trials
    • Our Research Team
    • Investigator-Initiated Research
  • About
    • Management Team
    • Board of Directors
    • Partnerships
  • Investors
  • Events & Presentations
  • Stock Information
  • News Releases
  • SEC Filings
  • Annual Reports
  • Analyst Coverage
  • Corporate Governance
  • Email Alerts
  • Investor FAQs

© 2022 Insmed Incorporated. All Rights Reserved. Terms of Use Privacy Policy

Culture
Patients
Science
logo
  • Culture
    • Mission & Vision
    • Careers
    • Responsibility
      • Inclusion at Insmed
      • Grants & Funding
      • Global Healthcare Compliance
  • Patients
    • Disease Areas
      • NTM Lung Disease
      • Bronchiectasis
      • Pulmonary Arterial Hypertension
    • Resources
    • Patient Access
  • Science
    • ARIKAYCE®
    • Our Programs
    • Pipeline
    • Clinical Trials
    • Our Research Team
    • Investigator-Initiated Research
  • About
    • Management Team
    • Board of Directors
    • Partnerships
  • Investors
    • Investors
    • Events & Presentations
    • Stock Information
    • News Releases
    • SEC Filings
    • Annual Reports
    • Analyst Coverage
    • Corporate Governance
    • Email Alerts
    • Investor FAQs

LinkedIn Twitter

Contact Us Job Opportunities

© 2022 Insmed Incorporated.
All Rights Reserved.

Terms of Use Privacy Policy